Testing a model for lymph node removal in lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a single lung nodule (or multiple nodules that are likely not cancer), and the main nodule may be a type of lung cancer called adenocarcinoma or squamous cell carcinoma.
- Your tumor is in stage I, II, or IIIA (early to moderately advanced) and can be removed with surgery.
- You are in good physical condition (able to do daily activities without help).
- Your lung function is good enough for surgery (FEV1 at least 1.0 liter and 80% of normal).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether 3D models from a CT scan without dye can help guide minimally invasive lung surgery. If you have a small early-stage lung cancer and are eligible for keyhole surgery, this study might be for you.
This study compares two surgical approaches for removing early-stage lung cancer (2-3 cm) from the outer part of the lung. It aims to see if removing only the affected segment (segmentectomy) is as effective as removing a larger portion of the lung (lobectomy), while potentially preserving more lung function.
This trial tests a new way to choose the best treatment for your lung cancer by creating a model of your tumor in the lab. It may help doctors find the most effective therapy for you.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.